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4Planas et al., 2013).
Deep sequencing allowed identiﬁcation and genomic characte
a possible pathogen from an ILI as well as being an important
future understanding of the linkages between viral genetic
transmission and disease prognosis.
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cluded inThe enveloped, negative-stranded human parainﬂuenza virus 4 (HPIV-4) is a member of t
Rubulavirus, family Paramyxoviridae, and a respiratory pathogen of children (Frost et al., 2013). It
quently included in diagnostic screening but some commercial assays have a detection capacity (F
2013; Loeffelholz et al., 2011). One third to one half of all HPIV-4 detections co-occur with ano
(Frost et al., 2013; Wang et al., 2012; Ren et al., 2011; Liu et al., 2013). When detected as the sole re
virus in ill children, HPIV-4 ismost often identiﬁed togetherwith fever, cough, and hypoxia, and pati
have a chest X-ray performed (Frost et al., 2013). Even when co-detected with another virus, clinic
teristics may not differ from when HPIV-4 is identiﬁed in isolation (Ren et al., 2011; Liu et al., 2013
has also been found in acute respiratory disease in adults (Liu et al., 2013; Chiu et al., 2006).While t
not frequently identiﬁed when it is sought, ongoing detections suggest sufﬁcient transmission to s
persistence in the human population, but relative to other respiratory viruses, little research has
ducted on HPIV-4.
In 1960HPIV-4was shown tohave two antigenically distinct subtypes (Johnson et al., 1960), sub
called HPIV-4a and HPIV-4b (Canchola et al.). An HPIV-4 virion contains a 15–17 kb negative-sen
stranded RNA genome. The ﬁrst complete genome sequence of HPIV-4b was reported in 2009 (
2009) followed byHPIV-4a in 2011 (Komada et al., 2011). HPIV-4 encodes nucleoprotein (N), phosp
(P), V protein (V), matrix (M), fusion (F), haemagglutinin–neuraminidase (HN) and large (L) prod
As part of a human virus discovery and characterisation programme, a 454 GS FLX deep sequen
ysis identiﬁed three short sequences suggestive of a divergent variant of an HPIV-4a present in a sa
lected from an adult with prolonged inﬂuenza-like illness. Here we report the sequencing of the g
that variant, HPIV-4a|QPID08-0015.
2. Results
2.1. Illness, sample preparation and 454 GS FLX deep sequencing process
Nucleic acids from the swab of a 35-year old female (35 F) from Victoria, Australia tested negat
viruses during initial real-time PCR (rtPCR) screening. 35 F had developed a prolonged inﬂuenza-l
(17-days; 28th April 2008 to 15th May 2008) that included signs of rhinorrhoea, nasal obstruc
throat, productive cough and systemic symptoms including chills, headache, myalgia and letharg
came ill after a similar illness in her partnerwhichwas followed by a subsequent illness in her 2-year
However, the nucleic acids include viral sequence fragments found by 454 GS FLX deep sequenc
sequences shared 83%–88% nucleotide identity with anHPIV-4a variant isolated in 1966 in Japan, HP
25 (GenBank accession number AB543336), as conﬁrmed using sequence alignments (CLC geno
bench, version 5.5.1), BLAST comparison and by phylogenetic analysis. The three fragments, eac
read, totalled 584 bp of non-overlapping sequence, representing 3% of the expected 17 kb HPIV-
(see Supplementary Figs. 1 and 2). Interestingly a second distinct HPIV-4, a variant of the other
HPIV-4b|Q-0493, was also identiﬁed from the same 2008 vaccine study sub-population using th
FLX deep sequencing process, but from a 49-year old male with ILI. Genome deduction of HPIV-4
which relied heavily on Sanger sequencing, was reported in the interim and this genome is also in
our analysis here (Bialasiewicz et al., 2014).
Before proceeding to deduce the complete coding region of QPID08-0015,we ﬁrst screened and conﬁrmed
the presence of anHPIV-4 in 35 F using our previously described speciﬁc diagnostic reverse transcriptase (RT)
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21K.E. Arden et al. / Virology Reports 5 (2015) 19–28rtPCR (Wang et al., 2012). This assay detects both viral subtypes, targeting a region of the relatively c
P-gene.
2.2. Improved nucleic acid preparation and deep sequencing process
To characterise the HPIV-4a variant's genome more rapidly than with Sanger sequencing and m
prehensively than with the 454 GS FLX approach, we employed our concentration, enrichment, pu
and ampliﬁcation (CEPA) process (Section 4.3) which yielded 69,230 100mer single-end Illum
reads (approximately 0.25% of all reads). These were mapped with at least a 70% overlap across 1
of the 17,140 bp HPIV-4a genome (Supplementary Fig. 2). The majority of the non-viral reads we
human sequence but these were not investigated further. A ﬁnal yield of 41 contiguous sequences
was obtained, ranging in size from 71 bp to 1250 bp with an average ﬁve-fold depth of coverage, d
across 90% of the genome. Gaps were subsequently closed after design of bespoke primers (Suppl
Table 1) and use of conventional RT-PCR using nucleic acids extracted from the same clinical sample
by Sanger sequencing to produce a single genome encompassing the entire coding sequence, entit
4a|QPID08-0015 (KF878965; Fig. 1). The complete genome followed a 3′-NP-P-M-F-HN-L-5′ conﬁg
2.3. HPIV-4a|QPID08-0015 genomic analysis and comparisons
A comparative scan of the complete coding regions of publicly available genomes, highlig
QPID08-0015 was an HPIV-4 most similar to the 4a subtype across all coding and non-coding reg
that there was more variability within genotypes of the HPIV-4a subtype than within those of the
subtype. Most nucleotide variation across the HPIV-4 genome, both between and within HPIV-4 g
occurred in the intergenic regions, while the L gene was the most conserved of the coding region
Phylogenetic analysis of each intergenic region from the complete genomes present on GenBank
that serotype demarcations were retained but relationships among the genotypes within HPIV-4a
as conserved (data not shown).
The genome of our genotype shared 97.7% nucleotide identitywithHPIV-4a|DK(459) and include
sequence insertion. Alquezar-Planas et al. identiﬁed upstreamofNP that is also present in theHPIV-4
and HPIV-4b|Q-0493, but had not been noted among HPIV-4a strains before (Alquezar-Planas et al
The L gene product is responsible for genome replication and is highly conserved within and
HPIV-4 subtypes (Henrickson, 2003). Reﬂecting the close genomic identity to HPIV-4a|DK(459), the
of HPIV-4a|QPID08-0015 was 99.5% identical at the amino acid level, reinforcing that these viruses
iants of the same genotype, distinct from other HPIV-4 genotypes andmembers of the family Paramy
(Fig. 3) (Alquezar-Planas et al., 2013).
Analysis of the majority of the variable hemagglutinin–neuraminidase (HN) envelope gene (Fig
tiﬁed the two HPIV-4 subtypes and conﬁrmed that HPIV-4a|QPID08-0015 and HPIV-4a|DK(459) arFig. 1. Relationships among HPIV-4 genomes. A phylogenetic analysis derived by neighbour-joining methods (500 bootstrap replicates)
comparing the HPIV-4a|QPID08-0015 (yellow star) genome against all available HPIV-4 genomes from GenBank (accession numbers in-
cluded the tree along with isolate name). Sequences (N17,100 nt) were aligned using Geneious v6 and a tree created using Mega 6
(Tamura et al., 2013). The tree is drawn to scale, mid-point rooted with branch lengths in the same units as those of the evolutionary dis-
tances used to infer the phylogenetic tree. HPIV-4 subtypes are indicated by coloured boxes.
of the same genotype detected at least ﬁve years apart and in different hemispheres (Alquezar-Planas et al.,
2013). The ﬁve amino acid C-terminal extension of the HN coding region noted by Alquezar-Planas is also
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Fig. 2. Pairwise distance scan of all complete HPIV-4a/b genomes. The coding regions (depicted as yellow boxes) from the HPIV-
4a|Qpid08-0015 genome have been overlayed onto the nucleotide distance scan to highlight location of regions with maximal sequence
variation. Sequence distances were calculated and plotted using Simmonics Sequence Editor software, version 1.1with a 250 nt fragment
incrementing by 25 nt between fragments (Simmonds, 2012).
22 K.E. Arden et al. / Virology Reports 5 (2015) 19–28part of the sequence of our variant and of HPIV-4b|Q-0493, conﬁrming that the longer ORF is no
(Alquezar-Planas et al., 2013). HPIV-4a|QPID08-0015 and HPIV-4a|DK(459) also share a one amin
terminal extension to the F protein that appears unique among the sequences from this region of a
4 genotype. The signiﬁcance of these extensions is unclear. A stretch of identical amino aci
(TQLLTYISYNGTI) was also present in HPIV-4a|QPID08-0015, identical to that found in other H
sequences on GenBank except for the frame-shifted HPIV-4a|Toshiba/M-25, HPIV-4b|04-13 a
4b|68-333 genomes as well as a single amino acid difference compared to the sequences of HPIV
Yamagata-2011 and HPIV-4b|2238-Yamagata-2011.
The 5′ and 3′ sequence termini of our variantwere not completely captured by the deep sequenc
od; however enough sequence was present to identify most of the 3′ genomic terminal
complementary termini (ICT; 5′-ATATCTCTTCTCCCCTTGGT-3′) present among the other HPIV-4 s
in our alignment (Yea et al., 2009; Hoffman and Banerjee, 2000). Of the full or near full-length genom
able on GenBank, HPIV-4b|SKPIV, HPIV-4b|04-13, HPIV-4b|68-333, HPIV-4a|M-25 and HPIV-4a|DK(
contained the 3′ copy of the ICT sequence. At the 5′ end there was a difference in ICT position; the H
terminal regions were ~500 nt in length from the stop codon, with the ICT sequence comprising th
5′ terminus, whereas HPIV-4a 5′ sequences were approximately ~235 nt long. with the ICT seque
comprising the ﬁnal 5′ positions. The 5′ ICT sequence could be identiﬁed in all HPIV-4 “complete” c
quences except for HPIV-4b|Q-0493 which did not appear to extend sufﬁciently. The HPIV-4 IC
among the longest ICT of any paramyxovirus. The differences in length between subtypes appeared to be a de-
ﬁning characteristic.
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Fig. 3. Relationships among the L gene protein of members of the Paramyxoviridae. A phylogenetic analysis derived by neighbour-joining
methods (500 bootstrap replicates) using L gene protein sequence from HPIV-4a|QPID08-0015 (yellow star) and reference sequences
from GenBank (accession number and isolate name included). Sequences (~2200 amino acids) were aligned using Geneious v6 and a
tree created using Mega 6 (Tamura et al., 2013). The tree is drawn to scale with branch lengths in the same units as those of the evolu-
tionary distances (computed using the Poisson correction (Zuckerkandl, 1965)) used to infer the phylogenetic tree. HeV—Hendra
virus; hMPV—humanmetapneumovirus; HPIV—human parainﬂuenza virus; MeV—measles virus; MuV—mumps virus; NDV—Newcastle
disease virus; NiV—Nipah virus; RPV—Rinderpest virus; RSV—respiratory syncytial virus; SeV—Sendai virus.
23K.E. Arden et al. / Virology Reports 5 (2015) 19–282.4. Detection and phylogeny of HPIV-4 in Queensland, Australia
Wehad previously sought HPIV-4 in the north-eastern Australian state of Queensland during 200
et al., 2012). Analysis of a ~500 nt portion of the P gene sequence identiﬁed examples of both subtyp
screening data were part of a previous report that did not include phylogeny (Wang et al., 2012).
examined the sequences here, we found no variants of the HPIV-4a|QPID08-0015 genotype circ
Queensland during 2008 when 35 F was ill in the southern State of Victoria (Fig. 5). However, fro
sequence analysis (Fig. 4), it appears that another variant of this genotypewas also circulating in Jap
2010 (HPIV4a|321-Yamagata-2010), conﬁrming this as a global virus.
3. Discussion
Wedescribe the discovery and genetic characterisation of a divergentHPIV-4a genotype detected
respiratory tract sample of an adult with prolonged signs and symptoms of an ILI during 2008 in the
Australian state of Victoria. This viral variantwas previously described in a child inDenmark in 2002/
was circulating in Japan in 2010 (Alquezar-Planas et al., 2013). Phylogenetic analysis of othe
detections from respiratory tract samples collected in Queensland, Australia in 2008 found no other instances
of this genotype in Queensland among a hospital-based population of young children (Wang et al., 2012). The
ther than
ing an ILI
tudy that
diagnos-
). Instead,
Fig. 4. Evolutionary relationships amongHPIV-4 HN gene sequences. A phylogenetic analysis derived by neighbour-joiningmethods (500
bootstrap replicates) using near-complete genomeHN gene sequences obtained fromGenBank (accession numbers included). Sequences
(~1700 nt) were aligned using Geneious v6 and a tree created using Mega 6 (Tamura et al., 2013). The tree is drawn to scale, mid-point
rootedwith branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. GenBank accession
numbers and HPIV-genotype, variant and subtype are indicated. The HPIV-4a|QPID08-0015 genotype is indicated by a yellow star.
24 K.E. Arden et al. / Virology Reports 5 (2015) 19–28current study highlights that viruses, even rarely sought and infrequently identiﬁed endemic ones o
inﬂuenza viruses, may be associated with ILI and reinforces that the virus associated with or caus
cannot be determined by clinical indications alone. This problem was recently highlighted in a s
found relatively few instances of the inﬂuenza A (H1N1)pdm09 virus sought by speciﬁc PCR-based
tics among people with a clinically deﬁned ILI during a time of pandemic (Ratnamohan et al., 2014
different viruses were subsequently identiﬁed and implicated yet not sought at that time.
We demonstrated that more sequence data were generated using our CEPA process compared to the 454
GS FLX approach which suggested to us that the combination of thoughtful specimen preparation and choice
verage as
, we were
hment for
ent and
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sequence
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ntly. Clin-
ate long-
material,
ing sufﬁ-
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nt of this
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Fig. 5.Relationships amongHPIV-4 genotypes identiﬁedby P gene sequencing from samples collected inQueensland andVictoria, 2008. A
phylogenetic analysis derived by neighbour-joining methods (500 bootstrap replicates) using partial P gene sequences obtained from
Queensland patients with acute respiratory illness (GenBank numbers prefaced by JP), an adult study member from Victoria (HPIV-
4a|QPID08-0015; yellow star) and reference sequences fromGenBank (accession numbers included alongwith isolate name). Sequences
(~500 nt) were aligned using Geneious v6 and a tree created using Mega 6 (Tamura et al., 2013). The tree is drawn to scale, mid-point
rooted with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree.
25K.E. Arden et al. / Virology Reports 5 (2015) 19–28of deep sequencing platform can signiﬁcantly aid the production of higher levels of viral genome co
we observed when using an identical clinical sample. After we concentrated and enriched for RNA
able to use Illumina deep sequencing to obtain 90% of the 17kb genome froma clinical sample. Enric
DNA could also be performed to seek other passengers or potential pathogens. Prior to enrichm
Illumina sequencing, 454 GS FLX technology and a basic nucleic acid extraction protocol could onl
sequence covering 3% of the HPIV-4a_QPID08-0015 genome represented by just three single
reads. In our experience, the amount of viral nucleic acid in human clinical samples can be very low
may be collected too early or late to capture a peak viral load and theymay originate from an inadeq
ple collection or be collected from a body site other than that where the virus replicates most efﬁcie
ical samples are sometimes treated poorly with insufﬁcient maintenance of a cold chain, inadequ
term storage and multiple rounds of freezing and thawing, all of which can degrade viral genomic
further reducing both the quantity and quality of the target available for molecular studies. Obtain
cient sequence to gain a foothold in any viral genome sequencing project can pose a challenge for
covery and characterisation.
The HPIV-4a|QPID08-0015 variant harboured the same genetic features as that of a Danish varia
genotype, including some features that had previously been noted only in HPIV-4b genotypes. In pa
sharedwith HPIV-4a|DK(459), HPIV-4b|SKPIV and HPIV-4b|Q-0493 a 57-nt insertion that has been suggested
to have a role in RNA replication, yet it is not present in all paramyxoviruses, nor in all HPIV-4 genotypes.
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26 K.E. Arden et al. / Virology Reports 5 (2015) 19–28While the insert may represent a shared evolutionary event between the HPIV-4a and HPIV-4b
the remaining majority of the genomes of these subtypes are consistently distinct. HPIV-4a|QPID
also contained a conserved 13 amino acid HN motif identical to that found among nearly all HPIV
quences. Given that it is part of a viral envelope protein, the conservationmay indicate a region of im
for HPIV-4 and perhaps one of that is sequestered away from host immune pressure. The HPIV-4
DK(459) and QPID08-0015 also shared C-terminal extension of the F and HN proteins.
Deep sequencing methods played a signiﬁcant role in improving our ability to rapidly ide
genomically characterise the infection in 35 F, monitor the performance of previously published d
and discover a new viral variant when targeted characterisation methods either failed or yield po
Unknown or undeﬁned genetic variants of classical viruses have the potential to confound existin
acid diagnosticmethods by reducing the efﬁciency of oligonucleotide priming, resulting in very late
nal or false negative results. However, in this instance our recently developed RT-rtPCR assaywas no
by genetic variation and could detect the divergent HPIV-4a|QPID08-0015. Further studies of HPIV-
would help to elucidate the full scope of HPIV-4 diversity and better deﬁne the signiﬁcance of the 3
sert sequence, the conserved envelopemotif, the frame-shifted and variably sized HNORF, how diff
the length of the 5′ ICT impact on viral replication andwhether any roles can be ascribed to the exte
iability we identiﬁed in the noncoding regions of all HPIV-4 genotypes.
4. Materials and methods
4.1. Sample origin, preparation and 454 GS FLX deep sequencing process
Flocked nose and throat swabs (n=643)were collected during a previously described commun
study nestedwithin an inﬂuenza vaccine effectiveness trial for adults aged 18–64 years (Howard et
McCaw et al., 2012). Brieﬂy, the community study aimed to assess inﬂuenza vaccine efﬁcacy and
samples from adults with an inﬂuenza-like illness (ILI). The ILI was deﬁned by the presence of co
throat, runny nose or nasal congestion and at least one systemic symptom (fever greater/eq
37.8 °C, feverishness, chills or myalgia). Each dry ﬂocked swab was resuspended after addition of
PBS followed by vortexing for 20 s. Nucleic acids were extracted from a 200 μl aliquot using the Q
platform and the DX reagent pack (Qiagen, Australia) according to the manufacturer's instruction
puriﬁed nucleic acids were eluted into 150 μl of elution buffer. Of the 643 extracts, 299 were no
for any of more than 200 viruses or virus groups sought by our rtPCR screening panel (How
2013). The 299 samples were initially subjected to deep sequencing analysis using a Roche 454 GS
nium sequencing platform after sample-speciﬁc barcoded random-priming cDNA synthesis fol
PCR ampliﬁcation using barcode-speciﬁc primers, as described previously (Holtz et al., 2009).
4.2. HPIV-4 genotyping
We ampliﬁed and sequenced regions of the HPIV-4 P gene using conventional RT-PCR genotyp
(Wang et al., 2012; Hibbitts et al., 2003). Sanger sequencing used the BigDye cycle sequencing kit
Biosystems, Australia) according to the manufacturer's instructions and incorporated 2–5 μl of spi
(NucleoSpin Extract II, Macherey-Nagel, Australia) puriﬁed PCR product submitted for analysis on a
Biosystems 3730 DNA Analyser (Australian Equine Genetics Research Centre, University of Queens
4.3. Sample preparation for deep sequencing methods
TheCEPA processwas developed for application to clinical samples thought to contain divergent
for which other sequencing methods were too slow or performed unsatisfactorily. Using a thawed
the original vortexed swab suspension, we ﬁrst concentrated virions using a size-exclusion spi
(Amicon Ultra-0.5 centrifugal ﬁlter, Millipore) then enriched for viral and other RNAs by remo
DNA (TURBODNase, Applied Biosystems) before subjecting the RNA to IlluminaHiSeq 2000 deep se
4.4. Sequence analyses
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27K.E. Arden et al. / Virology Reports 5 (2015) 19–28The 100 bp single-end Illumina reads weremapped to the nearestmatching reference genomew
determined by BLAST analysis. Contiguous sequences were characterised by BLAST comparison and
ny. Sequence alignmentswere created usingGeneious v6.1.7 (Drummond et al., 2011) and phylogen
were constructed using MEGA6 (Tamura et al., 2013).
Comparative sequence distances were determined using Simmonics Sequence Editor (Simmon
4.5. Ethical approvals
Written consent was obtained from all original study participants. Studies were approved by
Children's Hospital Human Research Ethics Committees (Melbourne and Brisbane) and the Human
Protection ofﬁce of Washington University, respectively.
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